Search Results - "Yarboro, Cheryl H"

Identification and characterization of circulating human transitional B cells by Sims, Gary P., Ettinger, Rachel, Shirota, Yuko, Yarboro, Cheryl H., Illei, Gabor G., Lipsky, Peter E.

“…Murine B-cell development begins in bone marrow and results in the generation of immature transitional B cells that transit to the spleen to complete their…”
Get full text

Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: A prospective, open-label, dose-escalation study by Bulua, Ariel C., Mogul, Douglas B., Aksentijevich, Ivona, Singh, Harjot, He, David Y., Muenz, Larry R., Ward, Michael M., Yarboro, Cheryl H., Kastner, Daniel L., Siegel, Richard M., Hull, Keith M.

“…Objective To investigate the efficacy of etanercept in improving the symptoms and underlying inflammation in patients with tumor necrosis factor…”
Get full text

Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study by Illei, Gabor G., Shirota, Yuko, Yarboro, Cheryl H., Daruwalla, Jimmy, Tackey, Edward, Takada, Kazuki, Fleisher, Thomas, Balow, James E., Lipsky, Peter E.

“…Objective To assess the safety of interleukin‐6 receptor inhibition and to collect preliminary data on the clinical and immunologic efficacy of tocilizumab in…”
Get full text

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis by ILLEI, Gabor G, AUSTIN, Howard A, KLIPPEL, John H, BALOW, James E, BOUMPAS, Dimitrios T, CRANE, Marianna, COLLINS, Lee, GOURLEY, Mark F, YARBORO, Cheryl H, VAUGHAN, Ellen M, KUROIWA, Takashi, DANNING, Carol L, STEINBERG, Alfred D

“…Controlled trials in lupus nephritis have demonstrated that cyclophosphamide therapy is superior to corticosteroid therapy alone. The long-term effectiveness…”
Get full text

Anti–N‐methyl‐D‐aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus by Lapteva, Larissa, Nowak, Miroslawa, Yarboro, Cheryl H., Takada, Kazuki, Roebuck‐Spencer, Tresa, Weickert, Thomas, Bleiberg, Joseph, Rosenstein, Donald, Pao, Maryland, Patronas, Nicholas, Steele, Sonya, Manzano, Melissa, van der Veen, Jan Willem C., Lipsky, Peter E., Marenco, Stefano, Wesley, Robert, Volpe, Bruce, Diamond, Betty, Illei, Gabor G.

“…Objective To assess the association of cognitive dysfunction and depression with serum antibodies to N‐methyl‐D‐aspartate (NMDA) receptor (anti‐NR2) and…”
Get full text

IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis by McInnes, Iain B, Illei, Gabor G, Danning, Carol L, Yarboro, Cheryl H, Crane, Marianne, Kuroiwa, Takashi, Schlimgen, Ryan, Lee, Eric, Foster, Barbara, Flemming, Donald, Prussin, Calman, Fleisher, Thomas A, Boumpas, Dimitrios T

“…Psoriatic arthritis (PsA) provides an ideal disease model in which to investigate the bioactivities of potentially therapeutic cytokines at multiple sites of…”
Get full text

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis by Takada, Kazuki, Arefayene, Million, Desta, Zeruesenay, Yarboro, Cheryl H., Boumpas, Dimitrios T., Balow, James E., Flockhart, David A., Illei, Gabor G.

“…Objective Pulse cyclophosphamide is the treatment of choice for severe lupus nephritis. However, not all patients respond to this therapy, and gonadal toxicity…”
Get full text

Abnormal differentiation of memory T cells in systemic lupus erythematosus by Fritsch, Ruth D., Shen, Xinglei, Illei, Gabor G., Yarboro, Cheryl H., Prussin, Calman, Hathcock, Karen S., Hodes, Richard J., Lipsky, Peter E.

“…Objective The chemokine receptor CCR7 and the tumor necrosis factor receptor family member CD27 define 3 distinct, progressively more differentiated…”
Get full text

Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis by Yarboro, C H, Wesley, R, Amantea, M A, Klippel, J H, Pucino, F

“…To evaluate the antiemetic efficacy of a modified regimen of oral ondansetron and dexamethasone in patients with lupus nephritis undergoing treatment with…”
Get more information

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis : A randomized, controlled trial by GOURLEY, M. F, AUSTIN, H. A, SCOTT, D, YARBORO, C. H, VAUGHAN, E. M, MUIR, J, BOUMPAS, D. T, KLIPPEL, J. H, BALOW, J. E, STEINBERG, A. D

“…Uncertainty exists about the efficacy and toxicity of bolus therapy with methylprednisolone or of the combination of methylprednisolone and cyclophosphamide in…”
Get full text

A pilot study of the use of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus by Nowak, Miroslawa, Carrasquillo, Jorge A., Yarboro, Cheryl H., Bacharach, Steven L., Whatley, Millie, Valencia, Xavier, Takada, Kazuki, Brust, Douglas G., Illei, Gabor G.

“…Objective The 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET) technique provides information on uptake and metabolism of glucose in…”
Get full text

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy by BOUMPAS, D. T, AUSTIN, H. A, VAUGHAN, E. M, YARBORO, C. H, KLIPPEL, J. H, BALOW, J. E

“…To determine the risk for secondary amenorrhea after pulse cyclophosphamide therapy in premenopausal women with systemic lupus erythematosus. Controlled,…”
Get full text

Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis : Relations with indices of inflammation by KANIK, K. S, CHROUSOS, G. P, SCHUMACHER, H. R, CRANE, M. L, YARBORO, C. H, WILDER, R. L

“…To determine whether alterations in adrenocortical function occur early in the development of inflammatory joint disease, we examined patients with new onset…”
Get full text

Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis by Goldbach-Mansky, R, Lee, J M, Hoxworth, J M, Smith, 2nd, D, Duray, P, Schumacher, Jr, R H, Yarboro, C H, Klippel, J, Kleiner, D, El-Gabalawy, H S

“…In cancer the gelatinases [matrix metalloproteinase (MMP)-2 and MMP-9] have been shown to be associated with tissue invasion and metastatic disease. In…”
Get full text

Polyreactive antigen‐binding B cells are the predominant cell type in the newborn B cell repertoire by Chen, Zhi Jian, Wheeler, C. James, Shi, Wei, Wu, Ava J., Yarboro, Cheryl H., Gallagher, Michael, Notkins, Abner Louis

“…Polyreactive antibodies bind to a variety of different self and non‐self antigens. The B cells that make these antibodies express the polyreactive Ig receptor…”
Get full text

Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis by Kanik, K S, Hagiwara, E, Yarboro, C H, Schumacher, H R, Wilder, R L, Klinman, D M

“…To compare patterns of cytokine secretion in patients with new onset synovitis (< 1 yr duration, n = 14), chronic rheumatoid arthritis (RA) (n = 16), and…”
Get more information

Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers by Kotake, S, Schumacher, Jr, H R, Arayssi, T K, Gérard, H C, Branigan, P J, Hudson, A P, Yarboro, C H, Klippel, J H, Wilder, R L

“…Genetically determined differences in interleukin-10 (IL-10) and gamma interferon (IFN-gamma) responses in mice correlate with clearance of Chlamydia…”
Get full text

Adrenocorticotropin, Glucocorticoid, and Androgen Secretion in Patients with New Onset Synovitis/Rheumatoid Arthritis: Relations with Indices of Inflammation1 by Kanik, Keith S., Chrousos, George P., Schumacher, H. Ralph, Crane, Marianna L., Yarboro, Cheryl H., Wilder, Ronald L.

“…To determine whether alterations in adrenocortical function occur early in the development of inflammatory joint disease, we examined patients with new onset…”
Get full text

Adrenocorticotropin, Glucocorticoid, and Androgen Secretion in Patients with New Onset Synovitis/Rheumatoid Arthritis: Relations with Indices of Inflammation 1 by Kanik, Keith S., Chrousos, George P., Schumacher, H. Ralph, Crane, Marianna L., Yarboro, Cheryl H., Wilder, Ronald L.

Get full text

Gamma Interferon and Interleukin-10 Gene Expression in Synovial Tissues from Patients with Early Stages ofChlamydia-Associated Arthritis and Undifferentiated Oligoarthritis and from Healthy Volunteers by Shigeru Kotake, H. Ralph Schumacher Jr, Thurayya K. Arayssi, Herve C. Gérard, Patrick J. Branigan, Alan P. Hudson, Cheryl H. Yarboro, John H. Klippel, Ronald L. Wilder

“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text